Actavis Elizabeth LLC
FDA inspection history in Elizabeth, New Jersey, 2011 to 2017
- 2
- Form 483s
Every document, by year
- Form 483
2011: one Form 483; 2017: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2011One Form 483, at Elizabeth, New Jersey.
- 2011The longest 483 on file: 3 observations over 3 pages at Elizabeth, New Jersey.
- 2017One Form 483, at Elizabeth, New Jersey.
Cited most
Across all Actavis Elizabeth observations on file
- 21 CFR 314.80(b)Postmarketing reporting of adverse drug experiences3
- 21 CFR 211.165Testing and release for distribution1
The complete Actavis Elizabeth file.
All 2 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
Elizabeth, New Jersey
Two Form 483s · 2011 to 2017 · 4 observations
Latest: Form 483, Feb 15, 2017 →
Documents
2 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2017-02-15 | 483 Form 483 | Elizabeth, New Jersey | 1 | $99 |
| 2011-04-26 | 483 Form 483 | Elizabeth, New Jersey | 3 | $99 |
Investigators on these documents
Erin D. McCaffery (1)Guerlain Ulysse (1)Michael Serrano (1)Sachinkumar V. Patel (1)Yvesna Blaise (1)
FEI number 2211563 · most recent document Feb 15, 2017
About Actavis Elizabeth LLC
How many FDA Form 483s has Actavis Elizabeth LLC received?
FDA Intel has 2 Form 483s on file for Actavis Elizabeth LLC; the most recent is dated Feb 15, 2017.
When was Actavis Elizabeth LLC last inspected by FDA?
The most recent FDA inspection document on file for Actavis Elizabeth LLC is a Form 483 dated Feb 15, 2017, for the site in Elizabeth, New Jersey.
What did FDA cite at Actavis Elizabeth LLC?
The regulations cited most in the observations on file for Actavis Elizabeth LLC are 21 CFR 314.80(b) (Postmarketing reporting of adverse drug experiences), 3 times; 21 CFR 211.165 (Testing and release for distribution), 1 time.